Data / Form D filings / Montara Therapeutics, Inc.
Montara Therapeutics, Inc.: Form D filings
Montara Therapeutics, Inc., a biotechnology company in San Francisco, CA, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on March 13, 2025, reports $20 million sold of a $20 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 135 MISSISSIPPI STREET, San Francisco, CA, 94107
- Phone
- (310) 463-6172
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2008775
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | New notice | $19,999,995 | $19,999,995 | 9 | Feb 26, 2025 | sec.gov | |
| Jan 19, 2024 | New notice | $17,000,022 | $8,000,011 | $9,000,011 | 5 | Jan 5, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Max Lebovitz | Executive Officer | |
| Seth Stratton | Director | |
| Troy Wilson | Director | |
| Zachary Hill | Executive Officer | |
| Rishi Rakhit | Executive Officer | |
| Randall Chin | Executive Officer | |
| Dirk Langdorf | Director | |
| Nicholas Hertz | Executive Officer, Director, Promoter |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 10, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Montara Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.